Application 213032
- Type
- ANDA
- Sponsor
- SUNSHINE LAKE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SILDENAFIL CITRATE | SILDENAFIL CITRATE | TABLET;ORAL | EQ 25MG BASE | No | No |
| 002 | SILDENAFIL CITRATE | SILDENAFIL CITRATE | TABLET;ORAL | EQ 50MG BASE | No | No |
| 003 | SILDENAFIL CITRATE | SILDENAFIL CITRATE | TABLET;ORAL | EQ 100MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 48792-7911 | Sildenafil | Sildenafil | Sunshine Lake Pharma Co., Ltd | ANDA | Current |
| 48792-7912 | Sildenafil | Sildenafil | Sunshine Lake Pharma Co., Ltd | ANDA | Current |
| 48792-7913 | Sildenafil | Sildenafil | Sunshine Lake Pharma Co., Ltd | ANDA | Current |